# Quanex Building Products CORP: overview

NX · NYSE · CIK 1423221 · [Materials](/sectors/materials.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/nx.md) · [Financials](/companies/nx/financials.md) · [Filings](/companies/nx/filings.md) · [Insiders](/companies/nx/insiders.md)

Latest reported revenue: [$501.8m](/filings/0001423221-26-000048.md) for Q3 FY2026, three months to 2026-07-31, from the 10-Q filed Sep 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001423221-26-000048).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [492 d](/filings/0001423221-25-000100.md) | [400](/filings/0001423221-26-000017.md) | [452](/filings/0001423221-26-000034.md) | [495](/filings/0001423221-26-000048.md) | [490 d](/filings/0001423221-25-000100.md) | [409](/filings/0001423221-26-000017.md) | [462](/filings/0001423221-26-000034.md) | [502](/filings/0001423221-26-000048.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [0.6% d](/filings/0001423221-25-000100.md) | [(1.7%)](/filings/0001423221-26-000017.md) | [9.0%](/filings/0001423221-26-000034.md) | [(54.7%)](/filings/0001423221-26-000048.md) | [8.8% d](/filings/0001423221-25-000100.md) | [0.7%](/filings/0001423221-26-000017.md) | [4.0%](/filings/0001423221-26-000034.md) | [9.3%](/filings/0001423221-26-000048.md) |
| Net margin | % | [(2.8%) d](/filings/0001423221-25-000100.md) | [(3.7%)](/filings/0001423221-26-000048.md) | [4.5%](/filings/0001423221-26-000048.md) | [(55.7%)](/filings/0001423221-26-000048.md) | [4.0% d](/filings/0001423221-25-000100.md) | [(1.0%)](/filings/0001423221-26-000048.md) | [0.7%](/filings/0001423221-26-000048.md) | [5.3%](/filings/0001423221-26-000048.md) |
| Diluted EPS | $ per share | not reported | [(0.32)](/filings/0001423221-26-000017.md) | [0.44](/filings/0001423221-26-000034.md) | [(6.04)](/filings/0001423221-26-000048.md) | not reported | [(0.09)](/filings/0001423221-26-000017.md) | [0.07](/filings/0001423221-26-000034.md) | [0.58](/filings/0001423221-26-000048.md) |
| Free cash flow | $m | [(8.2) d](/filings/0001423221-25-000100.md) | [(24.1)](/filings/0001423221-26-000017.md) | [13.6 d](/filings/0001423221-26-000034.md) | [46.2 d](/filings/0001423221-26-000048.md) | [66.6 d](/filings/0001423221-25-000100.md) | [(31.5)](/filings/0001423221-26-000017.md) | [7.9 d](/filings/0001423221-26-000034.md) | [47.8 d](/filings/0001423221-26-000048.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-10-31) | FY2022 (2022-10-31) | FY2023 (2023-10-31) | FY2024 (2024-10-31) | FY2025 (2025-10-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,072](/filings/0001423221-23-000016.md) | [1,222](/filings/0001423221-24-000015.md) | [1,131](/filings/0001423221-25-000100.md) | [1,278](/filings/0001423221-25-000100.md) | [1,838](/filings/0001423221-25-000100.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [7.6%](/filings/0001423221-23-000016.md) | [9.1%](/filings/0001423221-24-000015.md) | [9.8%](/filings/0001423221-25-000100.md) | [4.3%](/filings/0001423221-25-000100.md) | [(10.6%)](/filings/0001423221-25-000100.md) |
| Net margin | % | [5.3%](/filings/0001423221-23-000016.md) | [7.2%](/filings/0001423221-24-000015.md) | [7.3%](/filings/0001423221-25-000100.md) | [2.6%](/filings/0001423221-25-000100.md) | [(13.6%)](/filings/0001423221-25-000100.md) |
| Diluted EPS | $ per share | [1.70](/filings/0001423221-23-000016.md) | [2.66](/filings/0001423221-24-000015.md) | [2.50](/filings/0001423221-25-000100.md) | [0.90](/filings/0001423221-25-000100.md) | [(5.43)](/filings/0001423221-25-000100.md) |
| Free cash flow | $m | [54.6](/filings/0001423221-23-000016.md) | [64.8](/filings/0001423221-24-000015.md) | [110](/filings/0001423221-25-000100.md) | [51.7](/filings/0001423221-25-000100.md) | [102](/filings/0001423221-25-000100.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/nx/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $136.1m | 7,308,772 |  | Added +86,891 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $50.9m | 2,735,839 |  | Added +37,362 |
| [Allspring Global Investments Holdings, LLC](/funds/1890906.md) | 2026-06-30 | $42.9m | 2,383,553 |  | Reduced −324,105 |
| [TPG GP A, LLC](/funds/1903793.md) | 2026-06-30 | $38.3m | 2,054,770 |  | Unchanged |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $38.1m | 2,044,567 |  | Added +302,954 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $37.6m | 2,020,981 |  | Added +5,795 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $36.4m | 1,956,415 |  | Added +67,824 |
| [DEPRINCE RACE & ZOLLO INC](/funds/1008894.md) | 2026-06-30 | $33.9m | 1,820,614 |  | Reduced −23,791 |
| [SYSTEMATIC FINANCIAL MANAGEMENT LP](/funds/1085936.md) | 2026-06-30 | $33.8m | 1,815,276 |  | Added +39,024 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $33.6m | 1,801,860 |  | Added +45,948 |

## Recent filings

[All 1,145 filings](/companies/nx/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-04 | 16:03 ET | [10-Q](/filings/0001423221-26-000048.md) | Quarterly report, period 2026-07-31 | 0001423221-26-000048 |
| 2026-09-03 | 16:17 ET | [8-K](/filings/0001171843-26-005882.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005882 |
| 2026-08-27 | 16:17 ET | [8-K](/filings/0001171843-26-005764.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005764 |
| 2026-06-05 | 16:15 ET | [10-Q](/filings/0001423221-26-000034.md) | Quarterly report, period 2026-04-30 | 0001423221-26-000034 |
| 2026-06-04 | 16:17 ET | [8-K](/filings/0001171843-26-003917.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003917 |
| 2026-05-28 | 16:17 ET | [8-K](/filings/0001171843-26-003761.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-003761 |
| 2026-03-06 | 16:15 ET | [10-Q](/filings/0001423221-26-000017.md) | Quarterly report, period 2026-01-31 | 0001423221-26-000017 |
| 2026-03-05 | 16:17 ET | [8-K](/filings/0001171843-26-001364.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001364 |
| 2026-03-03 | 16:15 ET | [8-K](/filings/0001104659-26-022858.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-022858 |
| 2026-02-26 | 16:17 ET | [8-K](/filings/0001171843-26-001142.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-001142 |

## Latest annual report

[Form 10-K for the fiscal year ended Oct 31, 2025](/filings/0001423221-25-000100.md), filed Dec 12, 2025.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1423221
- Tickers: NX
- Exchange: NYSE
- SIC code: 3350 Rolling Drawing & Extruding of  Nonferrous Metals
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 20:52 ET. No prices; not investment advice.